Arthritis Res Ther
- POLLASTRO S, Musters A, Balzaretti G, Niewold I, et al
Sensitive B-cell receptor repertoire analysis shows repopulation correlates with
clinical response to rituximab in rheumatoid arthritis.
Arthritis Res Ther. 2024;26:70.
Clin Rheumatol
- GUPTA N, Kanwar N, Arora A, Khatri K, et al
The interplay of rheumatoid arthritis and osteoporosis: exploring the
pathogenesis and pharmacological approaches.
Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
- LU F, Chen Q, Qi X, Cong M, et al
Revealing the changes in signaling pathways caused by tofacitinib in patients
with rheumatoid arthritis through RNA sequencing and the correlation with
clinical parameters.
Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
- XIE Y, Zhao H
Real respiratory infection risk in primary Sjogren's syndrome complicated
with interstitial lung disease.
Clin Rheumatol. 2024;43:1353.
- DAI W, He H
Commentary on the respiratory infection risk in primary Sjogren's syndrome
complicated with interstitial lung disease.
Clin Rheumatol. 2024;43:1419-1420.
- LIU X, Wang H, Wang X, Jiang X, et al
Identification and verification of inflammatory biomarkers for primary Sjogren's
syndrome.
Clin Rheumatol. 2024;43:1335-1352.
Curr Opin Rheumatol
- FOX DA
Rheumatoid arthritis - the challenge of heterogeneity.
Curr Opin Rheumatol. 2024;36:201-202.
Intern Med
- SHIMIZU M, Fujimaki M, Igami E, Ishiguro Y, et al
Subacute Progressive Hearing Loss and Lower Body Parkinsonism in Primary
Sjogren's Syndrome.
Intern Med. 2024;63:853-856.
- NAKAYAMA Y, Sawa N, Suwabe T, Yamanouchi M, et al
Histologically Proven Recurrent Synovitis after Nivolumab Treatment.
Intern Med. 2024;63:867-871.
J Rheumatol
- SUBDAR S, Hoens AM, White K, Hartfeld NMS, et al
An environmental scan and appraisal of patient online resources for managing
rheumatoid arthritis flares.
J Rheumatol. 2024 Mar 15:jrheum.2023-1025. doi: 10.3899/jrheum.2023-1025.
PLoS One
- SAKASHITA E, Nagatani K, Endo H, Minota S, et al
Biomarker combination predicting imminent relapse after discontinuation of
biological drugs in patients with rheumatoid arthritis in remission.
PLoS One. 2024;19:e0299450.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016